Learn more

BIO PHARMARTIS CO LTD

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    176,888
  • Filing trend
    ⇩ 100.0%
About

BIO PHARMARTIS CO LTD has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and foods and drinks are XIAN QIFU, Oculis SA and ZHENGZHOU TRADITIONAL CHINESE HOSPITAL OF ORTHOPAEDICS.

Patent filings per year

Chart showing BIO PHARMARTIS CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Lee Sang Joon 12
#2 Ahn Jae Soon 10
#3 Chang Kwan Young 9
#4 Nam Dae Sik 9
#5 Kang Kyoung Un 8
#6 Koo Hyoung Mo 7
#7 Cho Jae Min 7
#8 Lee Hyun Joo 7
#9 Kang Kyoung-Un 6
#10 Chang Kwan-Young 6

Latest patents

Publication Filing date Title
WO2018062941A1 Pharmaceutical composition for preventing or treating dementia and cognitive dysfunction, containing donepezil or pharmaceutically acceptable salt thereof and memantine or pharmaceutically acceptable salt thereof, and preparation method therefor
KR20180036579A Composition comprising complex for prevention and treatment of dementia and cognitive impairment
KR20140140353A Oral combined formulation with improved stability and compatibility
KR20140120191A Pharmaceutical compositions for easy control of releasing pattern of lacosamide or pharmaceutically acceptable salts thereof
KR20140094679A Controlled release pharmaceutical composition comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR20140050354A Expandable mini-tablet comprising digestive enzyme
WO2012148225A2 Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
KR20130067695A Orally disintegrating tablet and process for preparing the same
KR20130020740A Delayed release formulation comprising duloxetine or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR20130010044A Sustained-release pharmaceutical composition comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR20130009906A Solid preparation for oral administration comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR20120055313A Sustained-release pharmaceutical composition comprising levetiracetam or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
KR20120048448A A composition for treating or preventing osteoporosis comprising ibandronic acid and a method of preparing the same